Catalyst Pharmaceuticals (CPRX) Tax Provisions (2019 - 2026)
Catalyst Pharmaceuticals' (CPRX) quarterly Tax Provisions came in at $20.5 million in Q1 2026, up 40.87% YoY from $14.5 million in Q1 2025, and up 114.56% on a QoQ basis from $9.6 million in Q4 2025.
Catalyst Pharmaceuticals (CPRX) Tax Provisions (2019 - 2026) Analysis & Trends
Catalyst Pharmaceuticals (CPRX) has 8 years of Tax Provisions data on file, last reported at $20.5 million in Q1 2026.
- Quarterly Tax Provisions rose 40.87% year-over-year to $20.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $65.5 million (up 7.16% YoY) and the FY2025 annual result came in at $59.5 million, up 13.68% from the prior year.
- Tax Provisions climbed to $20.5 million in Q1 2026, from $9.6 million in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $29.7 million in Q4 2023 to a low of -$7.3 million in Q3 2023.
- A 5-year average of $11.5 million and a median of $10.8 million in 2023 frame the typical range for Tax Provisions.
- The widest YoY moves for Tax Provisions: up 293.63% in 2023, down 322.68% in 2023.
- Tracing CPRX's Tax Provisions over 5 years: stood at $7.5 million in 2022, then soared by 293.63% to $29.7 million in 2023, then slumped by 38.5% to $18.2 million in 2024, then sank by 47.65% to $9.6 million in 2025, then soared by 114.56% to $20.5 million in 2026.
- The last three Tax Provisions figures came in at $20.5 million (Q1 2026), $9.6 million (Q4 2025), and $18.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 59.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 75.45 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 267.73 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.31 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 3.09 Bn | 134.92 Mn | 20.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.50 Mn |
| Dec 31, 2025 | 9.55 Mn |
| Sep 30, 2025 | 18.25 Mn |
| Jun 30, 2025 | 17.19 Mn |
| Mar 31, 2025 | 14.55 Mn |
| Dec 31, 2024 | 18.25 Mn |
| Sep 30, 2024 | 13.32 Mn |
| Jun 30, 2024 | 14.99 Mn |
| Mar 31, 2024 | 5.81 Mn |
| Dec 31, 2023 | 29.67 Mn |
| Sep 30, 2023 | -7.26 Mn |
| Jun 30, 2023 | 10.75 Mn |
| Mar 31, 2023 | 7.75 Mn |
| Dec 31, 2022 | 7.54 Mn |
| Sep 30, 2022 | 3.26 Mn |
| Jun 30, 2022 | 6.63 Mn |
| Mar 31, 2022 | 4.22 Mn |
| Dec 31, 2021 | 3.50 Mn |
| Sep 30, 2021 | 3.74 Mn |
| Jun 30, 2021 | 3.72 Mn |